NEW YORK – Beam Therapeutics on Tuesday disclosed initial clinical data, including one patient death, in a Phase I/II trial of its investigational sickle cell disease (SCD) gene-editing therapy ...

NEW YORK – Inify Laboratories on Tuesday said it has partnered with researchers at Karolinska Institutet to improve prostate cancer diagnosis through artificial intelligence-driven image analysis.

The government payor said it will separately pay for specialized diagnostic radiopharmaceuticals without transitional pass-through payment status.

The FDA has cleared an investigational new drug application enabling the company to begin a Phase I trial of HG202 in patients with the eye disorder.

The company will use the funds to enroll a registrational trial for its investigational gene therapy NGN-401 for Rett Syndrome.

The drugmaker emphasized plans to move further away from singular reliance on Keytruda while reporting solid sales growth in ...

A half-dozen hospital systems plan to implement the tool, which combs through patient medical records to identify those ...

Several new studies appear to confirm the test's potential to prevent overtreatment of melanoma patients while identifying those at high risk.

In the new arms, patients with certain biomarker-defined tumors will receive either an HLA-G targeted antibody, chemo, and Erbitux, or just chemo and Erbitux.

Based on early, interim data, Lexeo is already positioning its gene therapy as a potentially safer alternative than available anti-amyloid drugs.

Eisai has argued that maintenance dosing with Leqembi will prolong treatment benefits by targeting protofibrils, a toxic form of beta-amyloid.